Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion type Assertion NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_head.
- NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion wasGeneratedBy ECO_0000203 NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_provenance.
- NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion wasDerivedFrom befree-2016 NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_provenance.
- NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion SIO_000772 19780758 NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_provenance.
- NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion evidence source_evidence_literature NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_provenance.
- NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_provenance.